The project’s objectives are:
- Develop a knowledge base and guidelines for polymeric nanobiomaterials for drug delivery using Safer-by-Design approach
- Developing and implementing SbD thinking in the innovation process
- Consolidate and verify SbD approach in real industrial driven case studies using Chitosan, Polylactic acid (PLA) and Polyhydroxyalkanoate (PHA)
- consolidate these guidelines with industry and regulatory agencies to develop a comprehensive document for industry
- Disseminate the developed knowledge and concepts, and develop and offer training modules
- Reduce uncertainties and commercial risks for polymeric nanobiomaterials drug delivery applications